The in vitro effect of pidotimod on some immune functions in cancer patients.

被引：11

作者：

DiRenzo, M ^{[1
]}

Pasqui, AL ^{[1
]}

Bruni, F ^{[1
]}

Saletti, M ^{[1
]}

Bova, G ^{[1
]}

Chiarion, C ^{[1
]}

Girardello, R ^{[1
]}

Ferri, P ^{[1
]}

Auteri, A ^{[1
]}

机构：

[1] POLI IND CHIM SPA,ROZZANO,MI,ITALY

来源：

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY | 1997年 / 19卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

There are several reports concerning an impairment of cellular immune response in patients affected by malignant disease. The aim of this study was to evaluate the in vitro effect of Pidotimod, a synthetic biological response modifier, on some immune functions in 14 cancer patients. In particular, we showed that these subjects had a significantly reduced peripheral blood mononuclear cell (PBMC) proliferation both in response to PHA and to Con A in comparison with a group of healthy subjects. Besides, they showed a significantly reduced PBMC IL2 production, which was evaluated both through an ELISA method and a biological assay. The in vitro addition of increasing concentrations of Pidotimod (10, 25 and 50 ug/ml) was able to enhance PBMC proliferation and IL2 production significantly. However, in spite of the addition of Pidotimod, both immune functions in our neoplastic patients did not reach normal values.

引用

页码：37 / 51

页数：15

共 33 条

[1]

ANASTASOPOULOS E, 1992, ANTICANCER RES, V12, P489

[2]

AUTERI A, 1993, INT J IMMUNOTHER, V9, P95

[3]

AUTERI A, 1992, Pharmacological Research, V26, P196, DOI 10.1016/1043-6618(92)90662-U

[4]

DEPRESSED LEVELS OF GRANULAR LYMPHOCYTES WITH NATURAL-KILLER (NK) CELL-FUNCTION IN 247 CANCER-PATIENTS [J].

BALCH, CM ;

TILDEN, AB ;

DOUGHERTY, PA ;

CLOUD, GA ;

ABO, T .

ANNALS OF SURGERY, 1983, 198 (02) :192-199

[5]

BAXEVANIS CN, 1993, NAT IMMUN, V12, P41

[6]

INTERLEUKIN-2 PRODUCTION USED TO DETECT ANTIGENIC PEPTIDE RECOGNITION BY T-HELPER LYMPHOCYTES FROM ASYMPTOMATIC HIV-SEROPOSITIVE INDIVIDUALS [J].

CLERICI, M ;

STOCKS, NI ;

ZAJAC, RA ;

BOSWELL, RN ;

BERNSTEIN, DC ;

MANN, DL ;

SHEARER, GM ;

BERZOFSKY, JA .

NATURE, 1989, 339 (6223) :383-385

[7]

THE DECREASED EXPRESSION OF CD3 XI-CHAINS IN CANCER-PATIENTS IS NOT REVERSED BY IL-2 ADMINISTRATION [J].

FARACE, F ;

ANGEVIN, E ;

VANDERPLANCKE, J ;

ESCUDIER, B ;

TRIEBEL, F .

INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (06) :752-755

[8]

FIGARELLA EF, 1984, JNCI-J NATL CANCER I, V73, P1

[9]

FINKE JH, 1993, CANCER RES, V53, P5613

[10]

FORTNER JG, 1980, SURG GYNECOL OBSTET, V150, P215

← 1 2 3 4 →